We are live on ! Find out more
KTC

Kistler-Tiffany Companies Portfolio holdings

AUM $616M
1-Year Est. Return 16.74%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+16.74%
3 Year Est. Return
+52%
5 Year Est. Return
+77.66%
10 Year Est. Return
+209.93%
AUM
$263M
AUM Growth
+$21.2M
Cap. Flow
+$14.5M
Cap. Flow %
5.51%
Top 10 Hldgs %
50.86%
Holding
604
New
28
Increased
145
Reduced
84
Closed
25

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$2.88M
2
EXC icon
Exelon
EXC
+$317K
3
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$313K
4
VZ icon
Verizon
VZ
+$279K
5
RTX icon
RTX Corp
RTX
+$272K

Sector Composition

Rank Sector Weight
1 Healthcare 9.99%
2 Technology 8.32%
3 Consumer Staples 4.58%
4 Communication Services 4.11%
5 Financials 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRC
601
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
7
+6
+600% +$128
FTR
602
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
4
-5
-56% -$10
GG
603
DELISTED
Goldcorp Inc
GG
-1,217
Closed -$14K
GCVRZ
604
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$0 ﹤0.01%
79

Similar funds

Kistler-Tiffany Companies's Q2 2019 Portfolio in Review

As of Q2 2019, Kistler-Tiffany Companies held 604 positions worth $263M, up 8.8% from $242M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Kistler-Tiffany Companies deployed $14.5M of net new capital in Q2 2019, opening 28 new positions and adding to 145 existing holdings. Its largest new stake was Dow Inc: 6,430 shares worth $317K.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was West Pharmaceutical, an estimated $2.88M trimmed.

  • Kistler-Tiffany Companies's largest Q2 2019 buy was Dow Inc: 6,430 shares worth $317K.
  • Kistler-Tiffany Companies added most to Mesa Laboratories in Q2 2019, an estimated $6.54M increase.
  • Kistler-Tiffany Companies's biggest Q2 2019 reduction was West Pharmaceutical, cutting an estimated $2.88M.
  • Kistler-Tiffany Companies fully exited Blackstone in Q2 2019, selling an estimated $251K.
  • Kistler-Tiffany Companies's ten largest holdings make up 51% of its $263M portfolio in Q2 2019.
  • Kistler-Tiffany Companies opened 28 new positions and closed 25 in Q2 2019.
  • Kistler-Tiffany Companies's portfolio value rose 8.8% quarter-over-quarter to $263M.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2019, filed 22 Jul 2019.